Skip to content
New to DAT Supply? Create a client account to view pricing, order samples and start your first order.
DAT Supply Log in
Navigation
Profile

Preferences

Choose your market — it sets your site and language.

Start order

Already a member? Log in

When to Split a Supplement Range by Gender Audience

When does splitting a supplement range into men's and women's lines pay off, and when does it just double your MOQ before either line has sold?

23 July 2026 · 8 min read

Who this is for

Who this article is for

Brand owners and category managers reviewing a private-label supplement project.

Section

The split is a marketing decision, not a formulation one

A men's and women's split is a packaging and positioning decision layered on top of a production process, not a change to how that process works. Two branded lines can run on the same base formula, the same format and the same production route; what differs is naming, artwork, shelf language and the audience each line is built to speak to. Treating the split as a manufacturing question is the fastest way to over-complicate a decision that is really about how you want to present the range to a buyer.

Some categories carry a visible audience skew before you do anything at all. Sports nutrition and creatine formats tend to draw a male-leaning audience in most retail conversations, while beauty-and-skin and collagen formats tend to draw a female-leaning one. Daily vitamins, sleep support and gut health formats, by contrast, usually sell across a mixed audience without any split at all. None of that skew comes from the formula needing to differ by audience; it comes from how the category is marketed and merchandised, which is exactly the layer a split is meant to address.

The practical test is simple: could you sell the same formula, in the same format, to both audiences under one name and one pack design, and still tell a coherent story on shelf? If the answer is yes, you don't need a split yet — you need a range that speaks to both audiences without diluting either message. If the answer is no, the split is solving a real problem, not a marketing preference.

Section

What Make it Yours changes, and what it doesn't

Make it Yours covers flavour, colour and shape changes on a formula that already works — the personalisation lane a men's and women's split usually reaches for first, because it lets two lines look and feel distinct without commissioning a new recipe. A softer colour palette and a different flavour profile on one line, a bolder palette and flavour on the other, sitting on the same underlying formulation: that is a Make it Yours decision, not a Custom Formula R&D one.

What Make it Yours does not touch is the active ingredients, the amounts, or any claim built on top of them — those changes belong to a separately scoped Custom Formula R&D project, because they change what the product actually is, not just how it looks and tastes. Product naming and label artwork sit inside the standard private label branding process either way, whichever personalisation lane you use, so a men's and women's split is mostly a branding exercise riding on top of one or two underlying formulas.

Knowing which lane you're in before you brief a manufacturer changes the conversation. A split built entirely on Make it Yours is a packaging and flavour brief; a split that also changes the formula for one audience is a two-project brief, with two separate timelines and two separate MOQ commitments to plan around.

Section

Reading the signal before you commit to two lines

The signal worth acting on is a pattern, not a single data point: a retail buyer who has asked for a distinct line more than once, a channel where one audience is buying a nominally unisex SKU at a rate the other audience isn't matching, or repeat customers who specifically ask when a version aimed at the other audience is coming. Any one of those, seen consistently across more than one sales cycle, is a real signal that a split would sell rather than just look tidy on a brand deck.

The signal not worth acting on alone is a competitor's line existing, a single customer comment, or an assumption about what the category should look like. A competitor running two lines tells you they made a decision, not that the decision was correct for your range, your channel mix or your production budget — and a single comment is an anecdote until a second and third customer say the same thing.

Write the signal down before you act on it. If you can point to the retailer conversation, the channel data, or the repeat pattern in a sentence, you have a decision you can defend to whoever signs off the production brief. If you can't, you're probably reacting to a feeling rather than a pattern, and the range will carry that uncertainty into the manufacturer conversation.

Section

The MOQ math behind a second branded line

Every branded line is its own SKU commitment at the production stage, and each one carries the MOQ that applies to the format and packaging you choose — from 1,000 units for a standard PET bottle, or from 2,500 units for doypack packaging, with Make it Yours personalisation also starting from 2,500 units. Split a range into two lines and you are not adding a variant to one commitment; you are running two commitments in parallel, one per line, even when both sit on the same base formula.

That doubling shows up first in inventory: two production runs mean two sets of finished stock sitting in a warehouse before either line has sold through, rather than one run you can sell into both audiences from. It shows up second in cash: two MOQ commitments tie up capital earlier than one does, well before either line has proven itself at retail or online. Neither cost is a reason to avoid a split the signal supports — but both are reasons to be certain the signal is real before you commit to both.

If the signal is directional but not yet certain, a doypack-only launch of the second line, or a Make it Yours variant of an existing SKU rather than a fully separate item, keeps the commitment lower while you find out whether the audience split actually sells.

Section

A sequencing model: prove the unisex SKU first

The lowest-risk sequence is to launch one strong, audience-neutral SKU first, let it earn its place through more than one production cycle, and only then decide whether a split pays for itself. A single well-built range gives you real sales data — who is actually buying it, through which channel, at what repeat rate — before you commit a second MOQ to a line built on assumption rather than evidence.

This is the same logic behind building a range around one hero SKU rather than launching a full range on day one: fewer commitments, a clearer signal, and a decision about what to add next that is grounded in what actually sold rather than what looked right on a moodboard. A men's and women's split is one of several directions a hero SKU's success can point toward — a new line, a new format, or a new category are the others, and the signal should tell you which one, not a preference.

If the unisex SKU's sales data already shows a clear split in who is buying — one channel skewing heavily toward one audience, one audience driving nearly all the repeat orders — you may not need to wait for a second cycle. The point of proving the SKU first is to replace assumption with evidence, and sometimes the evidence arrives sooner than expected.

Section

Retail, marketing and brand-story costs of running two lines

A second line does not just cost a second MOQ — it costs a second story. Two lines mean two sets of packaging copy, two shelf placements to manage if you sell through retail, and two audiences to speak to consistently across every channel you run, from a product page to a retailer's own listing. None of that is expensive in the way a production run is expensive, but all of it is ongoing work that a single range doesn't require.

Marketing attention that used to support one message now has to stretch across two, at least until both lines earn their own audience and their own repeat customers. Brands that split too early sometimes find the second line quietly under-supported — not because it was the wrong decision, but because the team never had capacity for two brand stories at once, only for one, and the original range's momentum slows while attention is divided.

None of this argues against a split the signal genuinely supports. It argues for treating the ongoing marketing commitment as part of the same decision as the MOQ commitment, rather than assuming a second line runs itself once the production order ships.

Section

Lead time and the production calendar for two branded lines

Lead time for a private label order is typically a planning range of 5–12 weeks, depending on format, packaging, the production slot available and the destination market, with the exact timeline confirmed during order setup. Running two branded lines means booking, at minimum, two production slots rather than one — and those two slots don't have to run in parallel, but they do have to be sequenced deliberately if you want both lines on shelf or online within the same launch window.

A split launched a full production cycle apart, rather than in the same window, changes the story you tell retailers and customers — sometimes for the better, if the second line's launch benefits from the first line's early sales as proof, and sometimes for the worse, if the market was expecting both at once. Decide the sequencing on purpose, as part of the production brief, rather than letting two separate slots land wherever the calendar happens to place them.

Section

Compliance ownership and the brief you bring to a manufacturer

Whichever structure you choose, compliance on the finished product, its claims and its on-pack labelling remains the brand owner's responsibility for every line you run — a manufacturer supports that review with product documentation, but splitting a range into two lines means two labels to review, not one, regardless of how similar the two formulas are underneath.

Before you bring a men's and women's split to a manufacturer, put the decision in writing: the signal that justifies it, whether it rests on Make it Yours or a genuinely new formula, the MOQ and cash commitment for both lines, and the sequencing you want across the production calendar. A brief that already answers those questions moves faster than one that asks the manufacturer to help you decide whether you need a split at all.

When the range's audience logic is settled, the next step is a manufacturer brief that spells it out — one line or two, one formula or two, and the production slots you need to make the launch dates work.

More from the library

Related articles

Editorial pieces in the same category and a few recent picks from across the library.

Range strategy

How to Choose the First Three SKUs for a New Range

A framework for choosing an opening range of three SKUs: sequencing formats, sizing MOQ commitment, and what to leave for a second wave.

Read article →
Range strategy

How to Build a Supplement Range Around a Hero SKU

Why one strong SKU beats a full range on day one, and how to tell when a candidate product is actually ready to lead a launch.

Read article →
Range strategy

A Compliance-Aware Approach to Building a Kids Range

A doctrine-level guide to building a kids supplement range: positioning without a health-outcome claim, format choice, and compliance ownership.

Read article →
Range strategy

When to Add a New SKU to Your Supplement Range

How to tell a real signal to extend your range from founder enthusiasm, and what a new SKU actually costs before you brief it.

Read article →
Range strategy

How to Plan a Seasonal Supplement Range Without Overreach

A planning framework for a seasonal supplement range: working backward from the selling window, lead-time discipline, and avoiding leftover stock.

Read article →
Range strategy

Making a Supplement Range Subscription-Ready

What makes a supplement range subscription-ready: format choice, sizing an opening SKU set, and planning production cadence around renewals.

Read article →
Range strategy

Building a supplement range that sells: the sequencing playbook

A sequencing guide to building a private-label supplement range: choosing first SKUs, earning the hero-SKU slot, and timing line extensions.

Read article →
Quality & sourcing

Allergen Management Basics for a New Supplement Brand

What a private-label brand owner needs to review on allergens: what the manufacturer declares, what stays on your own label, and when to check it again.

Read article →

Continue exploring

Project handoff

Explore the catalogue

These notes point at reviewed private-label concepts. Browse the catalogue, or start an order in the DAT portal when you're ready.

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Order documents, certificates and pricing are released through the client workspace in the DAT portal.

You will receive a short confirmation email. Order documents (specification, batch-specific COA, packaging documents) are released through the client workspace in the DAT portal once a brief is in place.